The results showed that BroccoMax supplementation significantly reduced tissue biomarkers, such as Ki-67 and HDAC3, in benign tissue, but not in ductal carcinoma in situ (DCIS) or invasive ductal carcinoma tissue [142]. This evidence concerns the gene HDAC3 and ductal breast carcinoma in situ.